Our experiences and suggestions with PEEK marker use in prostate cancer radiotherapy

Cenk Ahmet Sen

doi:10.5114/wo.2018.74394

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2018
vol. 22

Send email

Copy url:

abstract:

Letter to the Editor

Our experiences and suggestions with PEEK marker use in prostate cancer radiotherapy

Cenk Ahmet Sen

Contemp Oncol (Pozn) 2018; 22 (1): 47-49

DOI: https://doi.org/10.5114/wo.2018.74394

Online publish date: 2018/04/03

View full text Get citation

PlumX metrics:

Polyether ether ketone (PEEK), a material commonly used in industry, has recently been introduced in medicine. The use of PEEK in place of gold in gold marker implantation for prostate radiotherapy has been suggested to be advantageous because it is associated with a lower level of artefacts. In this study, we present a disadvantage of this newly introduced method, which has not yet been defined in the literature, and offer a solution for this problem to shed light on this issue, which has not yet been completely understood.

keywords:

Our experiences and suggestions with PEEK marker use in prostate cancer radiotherapy

Cenk Ahmet Sen

PEEK markers, fiducial markers, prostate